Jonathan P Graham - Net Worth and Insider Trading

Jonathan P Graham Net Worth

The estimated net worth of Jonathan P Graham is at least $19 Million dollars as of 2023-09-23. Jonathan P Graham is the EVP, Gen. Counsel & Secy. of Amgen Inc and owns about 37,333 shares of Amgen Inc (AMGN) stock worth over $10 Million. Jonathan P Graham is also the Senior VP & GC of Danaher Corp and owns about 34,606 shares of Danaher Corp (DHR) stock worth over $9 Million. Details can be seen in Jonathan P Graham's Latest Holdings Summary section.

Transaction Summary of Jonathan P Graham

To

Jonathan P Graham Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jonathan P Graham owns 2 companies in total, including Amgen Inc (AMGN) , and Danaher Corp (DHR) .

Click here to see the complete history of Jonathan P Graham’s form 4 insider trades.

Insider Ownership Summary of Jonathan P Graham

Ticker Comapny Transaction Date Type of Owner
AMGN Amgen Inc 2015-07-13 SVP & Gen. Counsel & Secy.
DHR Danaher Corp 2006-07-01 Senior VP and GC

Jonathan P Graham Latest Holdings Summary

Jonathan P Graham currently owns a total of 2 stocks. Among these stocks, Jonathan P Graham owns 37,333 shares of Amgen Inc (AMGN) as of May 10, 2022, with a value of $10 Million and a weighting of 53.76%. Jonathan P Graham also owns 34,606 shares of Danaher Corp (DHR) as of May 19, 2015, with a value of $9 Million and a weighting of 46.24%.

Latest Holdings of Jonathan P Graham

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AMGN Amgen Inc 2022-05-10 37,333 267.70 9,994,044
DHR Danaher Corp 2015-05-19 34,606 248.37 8,595,092

Holding Weightings of Jonathan P Graham


Jonathan P Graham Form 4 Trading Tracker

According to the SEC Form 4 filings, Jonathan P Graham has made a total of 3 transactions in Amgen Inc (AMGN) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Amgen Inc is the sale of 13,500 shares on May 10, 2022, which brought Jonathan P Graham around $3 Million.

According to the SEC Form 4 filings, Jonathan P Graham has made a total of 0 transactions in Danaher Corp (DHR) over the past 5 years. The most-recent trade in Danaher Corp is the sale of 30,232 shares on May 19, 2015, which brought Jonathan P Graham around $3 Million.

Insider Trading History of Jonathan P Graham

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jonathan P Graham Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jonathan P Graham Ownership Network

Ownership Network List of Jonathan P Graham

No Data

Ownership Network Relation of Jonathan P Graham


Jonathan P Graham Owned Company Details

What does Amgen Inc do?

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amjevita (biosimilar Humira).

Who are the key executives at Amgen Inc?

Jonathan P Graham is the SVP & Gen. Counsel & Secy. of Amgen Inc. Other key executives at Amgen Inc include VP & Finance & CAO Matthew C. Busch , SVP & Human Resources Derek Miller , and SVP & Business Development Rachna Khosla .

Amgen Inc (AMGN) Insider Trades Summary

Over the past 18 months, Jonathan P Graham made 1 insider transaction in Amgen Inc (AMGN) with a net sale of 13,500. Other recent insider transactions involving Amgen Inc (AMGN) include a net sale of 800 shares made by R Sanders Williams , a net sale of 9,558 shares made by Murdo Gordon , and a net sale of 6,600 shares made by Robert Eckert .

In summary, during the past 3 months, insiders sold 9,558 shares of Amgen Inc (AMGN) in total and bought 0 shares, with a net sale of 9,558 shares. During the past 18 months, 31,390 shares of Amgen Inc (AMGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 31,390 shares.

Amgen Inc (AMGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Amgen Inc Insider Transactions

No Available Data

Jonathan P Graham Mailing Address

Above is the net worth, insider trading, and ownership report for Jonathan P Graham. You might contact Jonathan P Graham via mailing address: 2099 Pennsylvania Avenue, Nw, 12th Floor, Washington Dc 20006.

Discussions on Jonathan P Graham

No discussions yet.